aluates Reports

$ 0.0

Automative

Global Gene Recombinant Protein Market Research Report 2026

Published Date: 2026-04-08

Report Code: QYRE-Auto-9U17285

Global Gene Recombinant Protein Market Research Report 2024

BUY CHAPTERS

Global Gene Recombinant Protein Market Research Report 2026

Code: QYRE-Auto-9U17285

Report

2026-04-08

Pages:129

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eurogentec S.A

GenScript

OriGene

Sino Biological

Abgenex

Promega

Bio-Techne

Merck KGaA

Abcam

Cytiva

Abnova Corporation

Ajinomoto

Miltenyi Biotec

Bio Techne Corporation

ACROBiosystems

Reprocell

BPS Bioscience

Prospec-Tany Technogene

Thermo Fisher Scientific

Gene Recombinant Protein Market

The global Gene Recombinant Protein market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Genetically recombinant protein is a protein produced using genetic engineering technology.

The North American market for Gene Recombinant Protein is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Gene Recombinant Protein is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Gene Recombinant Protein in Pharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Gene Recombinant Protein include Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Gene Recombinant Protein market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Recombinant Protein. The Gene Recombinant Protein market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Gene Recombinant Protein market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Gene Recombinant Protein manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Gene Recombinant Protein Market Report

Report Metric	Details
Report Name	Gene Recombinant Protein Market
Segment by Type	Cytokines Plasma Protein Factors Recombinant Hormone Interferon Growth Factors Clotting Factor Enzyme Others
Segment by Application	Pharmaceutical Scientific Research Cosmetic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, Cytiva, Abnova Corporation, Ajinomoto, Miltenyi Biotec, Bio-Techne Corporation, ACROBiosystems, Reprocell, BPS Bioscience, ProSpec Tany TechnoGene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Recombinant Protein companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Recombinant Protein Market report?

Ans: The main players in the Gene Recombinant Protein Market are Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, Cytiva, Abnova Corporation, Ajinomoto, Miltenyi Biotec, Bio-Techne Corporation, ACROBiosystems, Reprocell, BPS Bioscience, ProSpec Tany TechnoGene

What are the Application segmentation covered in the Gene Recombinant Protein Market report?

Ans: The Applications covered in the Gene Recombinant Protein Market report are Pharmaceutical, Scientific Research, Cosmetic, Others

What are the Type segmentation covered in the Gene Recombinant Protein Market report?

Ans: The Types covered in the Gene Recombinant Protein Market report are Cytokines, Plasma Protein Factors, Recombinant Hormone, Interferon, Growth Factors, Clotting Factor, Enzyme, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Recombinant Protein Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cytokines

1.2.3 Plasma Protein Factors

1.2.4 Recombinant Hormone

1.2.5 Interferon

1.2.6 Growth Factors

1.2.7 Clotting Factor

1.2.8 Enzyme

1.2.9 Others

1.3 Market by Application

1.3.1 Global Gene Recombinant Protein Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical

1.3.3 Scientific Research

1.3.4 Cosmetic

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Recombinant Protein Market Perspective (2021–2032)

2.2 Global Gene Recombinant Protein Growth Trends by Region

2.2.1 Global Gene Recombinant Protein Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Gene Recombinant Protein Historic Market Size by Region (2021–2026)

2.2.3 Gene Recombinant Protein Forecasted Market Size by Region (2027–2032)

2.3 Gene Recombinant Protein Market Dynamics

2.3.1 Gene Recombinant Protein Industry Trends

2.3.2 Gene Recombinant Protein Market Drivers

2.3.3 Gene Recombinant Protein Market Challenges

2.3.4 Gene Recombinant Protein Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Recombinant Protein Players by Revenue

3.1.1 Global Top Gene Recombinant Protein Players by Revenue (2021–2026)

3.1.2 Global Gene Recombinant Protein Revenue Market Share by Players (2021–2026)

3.2 Global Top Gene Recombinant Protein Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Gene Recombinant Protein Revenue

3.4 Global Gene Recombinant Protein Market Concentration Ratio

3.4.1 Global Gene Recombinant Protein Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Recombinant Protein Revenue in 2025

3.5 Global Key Players of Gene Recombinant Protein Head Offices and Areas Served

3.6 Global Key Players of Gene Recombinant Protein, Products and Applications

3.7 Global Key Players of Gene Recombinant Protein, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Gene Recombinant Protein Breakdown Data by Type

4.1 Global Gene Recombinant Protein Historic Market Size by Type (2021–2026)

4.2 Global Gene Recombinant Protein Forecasted Market Size by Type (2027–2032)

5 Gene Recombinant Protein Breakdown Data by Application

5.1 Global Gene Recombinant Protein Historic Market Size by Application (2021–2026)

5.2 Global Gene Recombinant Protein Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Gene Recombinant Protein Market Size (2021–2032)

6.2 North America Gene Recombinant Protein Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Gene Recombinant Protein Market Size by Country (2021–2026)

6.4 North America Gene Recombinant Protein Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Recombinant Protein Market Size (2021–2032)

7.2 Europe Gene Recombinant Protein Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Gene Recombinant Protein Market Size by Country (2021–2026)

7.4 Europe Gene Recombinant Protein Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Gene Recombinant Protein Market Size (2021–2032)

8.2 Asia-Pacific Gene Recombinant Protein Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Gene Recombinant Protein Market Size by Region (2021–2026)

8.4 Asia-Pacific Gene Recombinant Protein Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Gene Recombinant Protein Market Size (2021–2032)

9.2 Latin America Gene Recombinant Protein Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Gene Recombinant Protein Market Size by Country (2021–2026)

9.4 Latin America Gene Recombinant Protein Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Recombinant Protein Market Size (2021–2032)

10.2 Middle East & Africa Gene Recombinant Protein Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Gene Recombinant Protein Market Size by Country (2021–2026)

10.4 Middle East & Africa Gene Recombinant Protein Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Gene Recombinant Protein Introduction

11.1.4 Thermo Fisher Scientific Revenue in Gene Recombinant Protein Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Eurogentec

11.2.1 Eurogentec Company Details

11.2.2 Eurogentec Business Overview

11.2.3 Eurogentec Gene Recombinant Protein Introduction

11.2.4 Eurogentec Revenue in Gene Recombinant Protein Business (2021–2026)

11.2.5 Eurogentec Recent Development

11.3 GenScript

11.3.1 GenScript Company Details

11.3.2 GenScript Business Overview

11.3.3 GenScript Gene Recombinant Protein Introduction

11.3.4 GenScript Revenue in Gene Recombinant Protein Business (2021–2026)

11.3.5 GenScript Recent Development

11.4 OriGene

11.4.1 OriGene Company Details

11.4.2 OriGene Business Overview

11.4.3 OriGene Gene Recombinant Protein Introduction

11.4.4 OriGene Revenue in Gene Recombinant Protein Business (2021–2026)

11.4.5 OriGene Recent Development

11.5 Sino Biological

11.5.1 Sino Biological Company Details

11.5.2 Sino Biological Business Overview

11.5.3 Sino Biological Gene Recombinant Protein Introduction

11.5.4 Sino Biological Revenue in Gene Recombinant Protein Business (2021–2026)

11.5.5 Sino Biological Recent Development

11.6 Abgenex

11.6.1 Abgenex Company Details

11.6.2 Abgenex Business Overview

11.6.3 Abgenex Gene Recombinant Protein Introduction

11.6.4 Abgenex Revenue in Gene Recombinant Protein Business (2021–2026)

11.6.5 Abgenex Recent Development

11.7 Promega

11.7.1 Promega Company Details

11.7.2 Promega Business Overview

11.7.3 Promega Gene Recombinant Protein Introduction

11.7.4 Promega Revenue in Gene Recombinant Protein Business (2021–2026)

11.7.5 Promega Recent Development

11.8 Bio - Techne

11.8.1 Bio - Techne Company Details

11.8.2 Bio - Techne Business Overview

11.8.3 Bio - Techne Gene Recombinant Protein Introduction

11.8.4 Bio - Techne Revenue in Gene Recombinant Protein Business (2021–2026)

11.8.5 Bio - Techne Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Details

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Gene Recombinant Protein Introduction

11.9.4 Merck KGaA Revenue in Gene Recombinant Protein Business (2021–2026)

11.9.5 Merck KGaA Recent Development

11.10 Abcam PLC

11.10.1 Abcam PLC Company Details

11.10.2 Abcam PLC Business Overview

11.10.3 Abcam PLC Gene Recombinant Protein Introduction

11.10.4 Abcam PLC Revenue in Gene Recombinant Protein Business (2021–2026)

11.10.5 Abcam PLC Recent Development

11.11 Cytiva

11.11.1 Cytiva Company Details

11.11.2 Cytiva Business Overview

11.11.3 Cytiva Gene Recombinant Protein Introduction

11.11.4 Cytiva Revenue in Gene Recombinant Protein Business (2021–2026)

11.11.5 Cytiva Recent Development

11.12 Abnova Corporation

11.12.1 Abnova Corporation Company Details

11.12.2 Abnova Corporation Business Overview

11.12.3 Abnova Corporation Gene Recombinant Protein Introduction

11.12.4 Abnova Corporation Revenue in Gene Recombinant Protein Business (2021–2026)

11.12.5 Abnova Corporation Recent Development

11.13 Ajinomoto

11.13.1 Ajinomoto Company Details

11.13.2 Ajinomoto Business Overview

11.13.3 Ajinomoto Gene Recombinant Protein Introduction

11.13.4 Ajinomoto Revenue in Gene Recombinant Protein Business (2021–2026)

11.13.5 Ajinomoto Recent Development

11.14 Miltenyi Biotec

11.14.1 Miltenyi Biotec Company Details

11.14.2 Miltenyi Biotec Business Overview

11.14.3 Miltenyi Biotec Gene Recombinant Protein Introduction

11.14.4 Miltenyi Biotec Revenue in Gene Recombinant Protein Business (2021–2026)

11.14.5 Miltenyi Biotec Recent Development

11.15 Bio-Techne Corporation

11.15.1 Bio-Techne Corporation Company Details

11.15.2 Bio-Techne Corporation Business Overview

11.15.3 Bio-Techne Corporation Gene Recombinant Protein Introduction

11.15.4 Bio-Techne Corporation Revenue in Gene Recombinant Protein Business (2021–2026)

11.15.5 Bio-Techne Corporation Recent Development

11.16 ACROBiosystems

11.16.1 ACROBiosystems Company Details

11.16.2 ACROBiosystems Business Overview

11.16.3 ACROBiosystems Gene Recombinant Protein Introduction

11.16.4 ACROBiosystems Revenue in Gene Recombinant Protein Business (2021–2026)

11.16.5 ACROBiosystems Recent Development

11.17 Reprocell

11.17.1 Reprocell Company Details

11.17.2 Reprocell Business Overview

11.17.3 Reprocell Gene Recombinant Protein Introduction

11.17.4 Reprocell Revenue in Gene Recombinant Protein Business (2021–2026)

11.17.5 Reprocell Recent Development

11.18 BPS Bioscience

11.18.1 BPS Bioscience Company Details

11.18.2 BPS Bioscience Business Overview

11.18.3 BPS Bioscience Gene Recombinant Protein Introduction

11.18.4 BPS Bioscience Revenue in Gene Recombinant Protein Business (2021–2026)

11.18.5 BPS Bioscience Recent Development

11.19 ProSpec Tany TechnoGene

11.19.1 ProSpec Tany TechnoGene Company Details

11.19.2 ProSpec Tany TechnoGene Business Overview

11.19.3 ProSpec Tany TechnoGene Gene Recombinant Protein Introduction

11.19.4 ProSpec Tany TechnoGene Revenue in Gene Recombinant Protein Business (2021–2026)

11.19.5 ProSpec Tany TechnoGene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eurogentec S.A

GenScript

OriGene

Sino Biological

Abgenex

Promega

Bio-Techne

Merck KGaA

Abcam

Cytiva

Abnova Corporation

Ajinomoto

Miltenyi Biotec

Bio Techne Corporation

ACROBiosystems

Reprocell

BPS Bioscience

Prospec-Tany Technogene

Thermo Fisher Scientific

List of Tables

Table 1. Global Gene Recombinant Protein Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cytokines

Table 3. Key Players of Plasma Protein Factors

Table 4. Key Players of Recombinant Hormone

Table 5. Key Players of Interferon

Table 6. Key Players of Growth Factors

Table 7. Key Players of Clotting Factor

Table 8. Key Players of Enzyme

Table 9. Global Gene Recombinant Protein Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Gene Recombinant Protein Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Gene Recombinant Protein Market Size by Region (US$ Million), 2021–2026

Table 12. Global Gene Recombinant Protein Market Share by Region (2021–2026)

Table 13. Global Gene Recombinant Protein Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Gene Recombinant Protein Market Share by Region (2027–2032)

Table 15. Gene Recombinant Protein Market Trends

Table 16. Gene Recombinant Protein Market Drivers

Table 17. Gene Recombinant Protein Market Challenges

Table 18. Gene Recombinant Protein Market Restraints

Table 19. Global Gene Recombinant Protein Revenue by Players (US$ Million), 2021–2026

Table 20. Global Gene Recombinant Protein Market Share by Players (2021–2026)

Table 21. Global Top Gene Recombinant Protein Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Recombinant Protein Revenue, 2025

Table 22. Ranking of Global Top Gene Recombinant Protein Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Gene Recombinant Protein Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Gene Recombinant Protein, Headquarters and Area Served

Table 25. Global Key Players of Gene Recombinant Protein, Products and Applications

Table 26. Global Key Players of Gene Recombinant Protein, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Gene Recombinant Protein Market Size by Type (US$ Million), 2021–2026

Table 29. Global Gene Recombinant Protein Revenue Market Share by Type (2021–2026)

Table 30. Global Gene Recombinant Protein Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Gene Recombinant Protein Revenue Market Share by Type (2027–2032)

Table 32. Global Gene Recombinant Protein Market Size by Application (US$ Million), 2021–2026

Table 33. Global Gene Recombinant Protein Revenue Market Share by Application (2021–2026)

Table 34. Global Gene Recombinant Protein Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Gene Recombinant Protein Revenue Market Share by Application (2027–2032)

Table 36. North America Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Gene Recombinant Protein Market Size by Country (US$ Million), 2021–2026

Table 38. North America Gene Recombinant Protein Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Gene Recombinant Protein Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Gene Recombinant Protein Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Gene Recombinant Protein Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Gene Recombinant Protein Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Gene Recombinant Protein Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Gene Recombinant Protein Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Gene Recombinant Protein Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Gene Recombinant Protein Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Gene Recombinant Protein Market Size by Country (US$ Million), 2027–2032

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Gene Recombinant Protein Product

Table 54. Thermo Fisher Scientific Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Eurogentec Company Details

Table 57. Eurogentec Business Overview

Table 58. Eurogentec Gene Recombinant Protein Product

Table 59. Eurogentec Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 60. Eurogentec Recent Development

Table 61. GenScript Company Details

Table 62. GenScript Business Overview

Table 63. GenScript Gene Recombinant Protein Product

Table 64. GenScript Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 65. GenScript Recent Development

Table 66. OriGene Company Details

Table 67. OriGene Business Overview

Table 68. OriGene Gene Recombinant Protein Product

Table 69. OriGene Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 70. OriGene Recent Development

Table 71. Sino Biological Company Details

Table 72. Sino Biological Business Overview

Table 73. Sino Biological Gene Recombinant Protein Product

Table 74. Sino Biological Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 75. Sino Biological Recent Development

Table 76. Abgenex Company Details

Table 77. Abgenex Business Overview

Table 78. Abgenex Gene Recombinant Protein Product

Table 79. Abgenex Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 80. Abgenex Recent Development

Table 81. Promega Company Details

Table 82. Promega Business Overview

Table 83. Promega Gene Recombinant Protein Product

Table 84. Promega Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 85. Promega Recent Development

Table 86. Bio - Techne Company Details

Table 87. Bio - Techne Business Overview

Table 88. Bio - Techne Gene Recombinant Protein Product

Table 89. Bio - Techne Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 90. Bio - Techne Recent Development

Table 91. Merck KGaA Company Details

Table 92. Merck KGaA Business Overview

Table 93. Merck KGaA Gene Recombinant Protein Product

Table 94. Merck KGaA Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 95. Merck KGaA Recent Development

Table 96. Abcam PLC Company Details

Table 97. Abcam PLC Business Overview

Table 98. Abcam PLC Gene Recombinant Protein Product

Table 99. Abcam PLC Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 100. Abcam PLC Recent Development

Table 101. Cytiva Company Details

Table 102. Cytiva Business Overview

Table 103. Cytiva Gene Recombinant Protein Product

Table 104. Cytiva Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 105. Cytiva Recent Development

Table 106. Abnova Corporation Company Details

Table 107. Abnova Corporation Business Overview

Table 108. Abnova Corporation Gene Recombinant Protein Product

Table 109. Abnova Corporation Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 110. Abnova Corporation Recent Development

Table 111. Ajinomoto Company Details

Table 112. Ajinomoto Business Overview

Table 113. Ajinomoto Gene Recombinant Protein Product

Table 114. Ajinomoto Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 115. Ajinomoto Recent Development

Table 116. Miltenyi Biotec Company Details

Table 117. Miltenyi Biotec Business Overview

Table 118. Miltenyi Biotec Gene Recombinant Protein Product

Table 119. Miltenyi Biotec Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 120. Miltenyi Biotec Recent Development

Table 121. Bio-Techne Corporation Company Details

Table 122. Bio-Techne Corporation Business Overview

Table 123. Bio-Techne Corporation Gene Recombinant Protein Product

Table 124. Bio-Techne Corporation Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 125. Bio-Techne Corporation Recent Development

Table 126. ACROBiosystems Company Details

Table 127. ACROBiosystems Business Overview

Table 128. ACROBiosystems Gene Recombinant Protein Product

Table 129. ACROBiosystems Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 130. ACROBiosystems Recent Development

Table 131. Reprocell Company Details

Table 132. Reprocell Business Overview

Table 133. Reprocell Gene Recombinant Protein Product

Table 134. Reprocell Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 135. Reprocell Recent Development

Table 136. BPS Bioscience Company Details

Table 137. BPS Bioscience Business Overview

Table 138. BPS Bioscience Gene Recombinant Protein Product

Table 139. BPS Bioscience Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 140. BPS Bioscience Recent Development

Table 141. ProSpec Tany TechnoGene Company Details

Table 142. ProSpec Tany TechnoGene Business Overview

Table 143. ProSpec Tany TechnoGene Gene Recombinant Protein Product

Table 144. ProSpec Tany TechnoGene Revenue in Gene Recombinant Protein Business (US$ Million), 2021–2026

Table 145. ProSpec Tany TechnoGene Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Gene Recombinant Protein Picture

Figure 2. Global Gene Recombinant Protein Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Gene Recombinant Protein Market Share by Type: 2025 vs 2032

Figure 4. Cytokines Features

Figure 5. Plasma Protein Factors Features

Figure 6. Recombinant Hormone Features

Figure 7. Interferon Features

Figure 8. Growth Factors Features

Figure 9. Clotting Factor Features

Figure 10. Enzyme Features

Figure 11. Others Features

Figure 12. Global Gene Recombinant Protein Market Size by Application (US$ Million), 2021–2032

Figure 13. Global Gene Recombinant Protein Market Share by Application: 2025 vs 2032

Figure 14. Pharmaceutical Case Studies

Figure 15. Scientific Research Case Studies

Figure 16. Cosmetic Case Studies

Figure 17. Others Case Studies

Figure 18. Gene Recombinant Protein Report Years Considered

Figure 19. Global Gene Recombinant Protein Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 20. Global Gene Recombinant Protein Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Gene Recombinant Protein Market Share by Region: 2025 vs 2032

Figure 22. Global Gene Recombinant Protein Market Share by Players in 2025

Figure 23. Global Gene Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. The Top 10 and 5 Players Market Share by Gene Recombinant Protein Revenue in 2025

Figure 25. North America Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. North America Gene Recombinant Protein Market Share by Country (2021–2032)

Figure 27. United States Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Canada Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Europe Gene Recombinant Protein Market Share by Country (2021–2032)

Figure 31. Germany Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. France Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. U.K. Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Italy Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Russia Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Ireland Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Asia-Pacific Gene Recombinant Protein Market Share by Region (2021–2032)

Figure 39. China Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Japan Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. South Korea Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Southeast Asia Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. India Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Australia & New Zealand Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Latin America Gene Recombinant Protein Market Share by Country (2021–2032)

Figure 47. Mexico Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Brazil Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Middle East & Africa Gene Recombinant Protein Market Share by Country (2021–2032)

Figure 51. Israel Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Saudi Arabia Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. UAE Gene Recombinant Protein Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 55. Eurogentec Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 56. GenScript Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 57. OriGene Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 58. Sino Biological Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 59. Abgenex Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 60. Promega Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 61. Bio - Techne Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 62. Merck KGaA Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 63. Abcam PLC Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 64. Cytiva Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 65. Abnova Corporation Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 66. Ajinomoto Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 67. Miltenyi Biotec Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 68. Bio-Techne Corporation Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 69. ACROBiosystems Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 70. Reprocell Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 71. BPS Bioscience Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 72. ProSpec Tany TechnoGene Revenue Growth Rate in Gene Recombinant Protein Business (2021–2026)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Protein Expression System Market Research Report 2024

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Recombinant Therapeutic Protein Market Research Report 2025

Global Recombinant Antibody Market Research Report 2025

Global Prokaryotic Recombinant Protein Market Research Report 2024

Global Recombinant Protein Industrial Reagents Market Research Report 2024

Recombinant Protein Research Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Protein Vaccine Market Insights Forecast to 2030

Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Influenza Vaccine Market Research Report 2024

Recombinant Protein Therapeutics Market

Global Recombinant Trypsin Market Insights Forecast to 2030

Global Recombinant Protein Biological Research Reagents Market Research Report 2024

Recombinant Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Collagen for Cosmetics Market Research Report 2024

Global Alternative Protein Synthetic Biology Market Research Report 2024

Global Restructured Collagen for Skin Care Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions